 VALFIX Medical Inc. Announces the Appointment of Former Abbott Ventures DVP, Evan Norton as New Independent Board MemberBy: Valfix medical Inc. DOVER, Del. - Feb. 1, 2022 - PRLog -- VALFIX Medical Inc. announced today the appointment of former Abbott Venture Divisional Vice President (DVP), Mr. Evan Norton as the company's independent board member making him the company's fifth board of directors' member.
"We are delighted to have Evan on VALFIX's board of directors. His business and market experience and talents in MedTech innovation are extremely valuable assets as VALFIX continues to grow and we continue to advance our technology," Mr. Norton spent a decade with Abbott leading the corporate venture arm, Abbott Ventures. During this time, Mr. Norton managed the company's minority equity investments, structured transactions, and private company acquisitions on behalf of both Abbott's business units as well as developing entry strategies in white space markets. "I am delighted to join VALFIX's board of directors. When I was approached by Eli Bar with this opportunity and, after learning more about the VALFIX team and technology potential, I knew it was a company I wanted to be involved with," stated Evan. "I am confident in Eli's leadership, VALFIX's success to date in achieving their milestones, and the ongoing potential of the company. Mr. Norton has an MBA from Northwestern's Kellogg School of Management where he serves as an adjunct lecturer teaching "Medical Products Commercialization and Funding." About VALFIX Medical: VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative technology offers a viable alternative to open heart surgery. To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at info@valfixmed.com Media Contact: Devra Igra +972 73 374 4805 devra.igra@valfixmed.com End
|
Account Phone Number